Efficacy and Safety Study of Xyotax to Treat Prostate Cancer

NCT00446836 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

DRUG: Paclitaxel polyglumex (Xyotax)

Sponsor

The Methodist Hospital Research Institute

Collaborators

[object Object]